Canadian Insurer details on coverage for Wegovy for cardiovascular treatment
Chris Pryce2025-02-01T15:16:16+00:00GroupForce Benefit News January 2025
Drug Dispensing Fees – Ontario (July to Dec. 2017)
Chris Pryce2018-11-23T15:48:04+00:00Although, these figures are historical (not released regularly), it is easy to see that Plan Sponsors should be encouraging plan members to be wise consumers and to look at the cost that pharmacist are charging for professional drug dispensing fees. Since guidelines were enacted a number of years ago, aimed at eliminating certain incentives/rebates to [...]
Ontario government to become second payer under OHIP+ changes
Chris Pryce2018-07-12T22:01:36+00:00Ontario’s new Conservative government has announced changes to the province’s youth pharmacare program to make it second payer for Ontarians under age 25 who have coverage through private benefits plans. “Today, our government is announcing our intent to fix the OHIP+ program by focusing benefits on those who do not have existing prescription drug benefits,” [...]
Price reductions on nearly 70 generic drugs sold in Canada
Chris Pryce2018-04-17T15:54:10+00:00A new agreement between the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association will reduce the prices of nearly 70 generic drugs, including the most commonly prescribed medications. These include drugs used to treat conditions such as high blood pressure, high cholesterol and depression. Under the January 29 agreement, the prices of these generic [...]
OHIP+ and private payer impact
Chris Pryce2018-04-17T15:54:34+00:00As published in Benefits Canada Online http://bit.ly/2A5WBtG Although a national pharmacare strategy seems elusive, the Ontario government is making a fairly aggressive investment in that area by spending $465 million to boost its provincial drug coverage by covering residents under age 25 and from 65 onwards. The program, known as OHIP+, begins Jan. 1, 2018. Children [...]